The non-profit/for-profit joint venture model de-risks and optimizes therapeutic candidates by leveraging favorable regulatory indications and decreasing time to market.

AWARDS

We are XenoTherapeutics

We operate with cellular-to-surgical expertise, collaborating with subject matter experts and domain-focused teams in a streamlined corporate business model. Our partnerships replace the traditional need for brick-and-mortar expenses and offer services to a company like ours that were previously unattainable. 

Together, our team combines into a force that looks much bigger, operates much faster, and achieves more with less by comparison to our peers. We are reducing costs, compressing timelines, and speeding time to market.